AstraZeneca Cancer Drugs - Search News

News

AstraZeneca CEO on breast cancer drug trial

Bloomberg on MSN · 13h

Breast Cancer Growth Slowed by 14 Months in New AstraZeneca Drug Study

AstraZeneca Plc and Daiichi Sankyo Co.’s Enhertu delayed the advance of a common type of breast cancer by more than a year in a large study, a result that may lead to expanded use of the medicine.The treatment,

BioPharma Dive · 1d

AstraZeneca drug could help keep a common breast cancer at bay

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of initial treatment, potentially opening a novel step in patient care.

AstraZeneca Pill Cut Risk of Breast Cancer Death, Study Finds

Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding that could change the way such cancers are treated, cancer experts said on Sunday.

Investor's Business Daily on MSN13h

How AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion Pharma

Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.

BioPharma Dive12h

Enhertu potential broadens as new data point to frontline breast cancer role

Study results unveiled at ASCO show combining Enhertu with Perjeta can significantly delay tumor growth versus a regimen that ...

At ASCO Day 3, AstraZeneca dominates, Takeda reveals experimental drug data, Eli Lilly serves salad

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

The Astana Times15h

AstraZeneca, National Research Oncology Center Sign Memorandum to Advance Cancer Care

ASTANA – The National Research Oncology Center and the AstraZeneca biopharmaceutical company signed an agreement on May 30 to ...

1d

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer

Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

Fierce Pharma1d

ASCO: AstraZeneca looks to bring immunotherapy to early-stage stomach cancer with Imfinzi

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results